These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30937503

  • 1. Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
    Behere S, Alapati D, McCulloch MA.
    Pediatr Cardiol; 2019 Jun; 40(5):973-979. PubMed ID: 30937503
    [Abstract] [Full Text] [Related]

  • 2. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
    Montgomery AM, Bazzy-Asaad A, Asnes JD, Bizzarro MJ, Ehrenkranz RA, Weismann CG.
    Neonatology; 2016 Jun; 109(3):190-4. PubMed ID: 26780635
    [Abstract] [Full Text] [Related]

  • 3. Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia.
    Avitabile CM, Ansems S, Wang Y, Fraga MV, Kirpalani HM, Zhang H, Mercer-Rosa L, Jensen EA.
    Neonatology; 2019 Jun; 116(2):147-153. PubMed ID: 31096210
    [Abstract] [Full Text] [Related]

  • 4. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia.
    König K, Guy KJ, Nold-Petry CA, Barfield CP, Walsh G, Drew SM, Veldman A, Nold MF, Casalaz DM.
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec 01; 311(6):L1076-L1081. PubMed ID: 27760764
    [Abstract] [Full Text] [Related]

  • 5. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    Dasgupta S, Aly AM, Malloy MH, Okorodudu AO, Jain SK.
    J Perinatol; 2018 Sep 01; 38(9):1252-1257. PubMed ID: 29977013
    [Abstract] [Full Text] [Related]

  • 6. Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.
    Madden BA, Conaway MR, Zanelli SA, McCulloch MA.
    Pediatr Cardiol; 2022 Dec 01; 43(8):1743-1751. PubMed ID: 35488130
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.
    Savoia M, Morassutti FR, Castriotta L, Pavoni D, Mourani PM, Freschi P, Cattarossi L, Tonutti A.
    Eur J Pediatr; 2021 Jun 01; 180(6):1711-1720. PubMed ID: 33474582
    [Abstract] [Full Text] [Related]

  • 8. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS, Keller T, Kribs A, Hünseler C.
    Eur J Pediatr; 2023 Jul 01; 182(7):3075-3082. PubMed ID: 37072630
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
    Harris SL, More K, Dixon B, Troughton R, Pemberton C, Horwood J, Ellis N, Austin N.
    Eur J Pediatr; 2018 Apr 01; 177(4):521-532. PubMed ID: 29352349
    [Abstract] [Full Text] [Related]

  • 10. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.
    Check J, Gotteiner N, Liu X, Su E, Porta N, Steinhorn R, Mestan KK.
    J Perinatol; 2013 Jul 01; 33(7):553-7. PubMed ID: 23328924
    [Abstract] [Full Text] [Related]

  • 11. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T, Kulkarni M, Gokulakrishnan G, Shivanna B, Pammi M.
    J Perinatol; 2020 Apr 01; 40(4):607-615. PubMed ID: 31925319
    [Abstract] [Full Text] [Related]

  • 12. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
    Méndez-Abad P, Zafra-Rodríguez P, Lubián-López S, Benavente-Fernández I.
    Eur J Pediatr; 2019 May 01; 178(5):755-761. PubMed ID: 30820654
    [Abstract] [Full Text] [Related]

  • 13. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
    Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):87-95. PubMed ID: 25389562
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary hypertension in preterm infants: results of a prospective screening program.
    Weismann CG, Asnes JD, Bazzy-Asaad A, Tolomeo C, Ehrenkranz RA, Bizzarro MJ.
    J Perinatol; 2017 May 01; 37(5):572-577. PubMed ID: 28206997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age.
    Levy PT, Patel MD, Choudhry S, Hamvas A, Singh GK.
    J Pediatr; 2018 Jun 01; 197():48-56.e2. PubMed ID: 29625733
    [Abstract] [Full Text] [Related]

  • 18. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
    Kalra VK, Aggarwal S, Arora P, Natarajan G.
    Pediatr Pulmonol; 2014 Nov 01; 49(11):1106-11. PubMed ID: 24214578
    [Abstract] [Full Text] [Related]

  • 19. B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis.
    Cuna A, Kandasamy J, Sims B.
    BMC Pediatr; 2014 Mar 11; 14():68. PubMed ID: 24612708
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.